10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001558370-20-012946`
Period End Date	20200930
Filing Date	20201105
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	iova-20200930x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 65 Income Statement 32 Cash Flow Statement 55 Stockholders Equity 35 Comprehensive Income 12

Balance Sheet 65 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$38.89M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$68.31M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.97M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$645.84M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$293.11M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$9.44M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$9.41M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$316.49M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$723.59M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$39.11M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$8.54M	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$10.68M	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$10.70M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$5.45M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$5.45M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$5.53M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	126.41M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	146.58M	shares	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$3.38M	USD	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$3.48M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	126.41M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	146.58M	shares	Point-in-time
Total Assets	`Assets`	$782.29M	USD	Point-in-time
Total Assets	`Assets`	$344.65M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$15.57M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$24.79M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$32.40M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$16.27M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$7.20M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$7.25M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$39.08M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$64.39M	USD	Point-in-time
Operating lease liabilities - noncurrent	`OperatingLeaseLiabilityNoncurrent`	$4.25M	USD	Point-in-time
Operating lease liabilities - noncurrent	`OperatingLeaseLiabilityNoncurrent`	$3.71M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$2.35M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$2.35M	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$6.60M	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$6.06M	USD	Point-in-time
Total Liabilities	`Liabilities`	$70.45M	USD	Point-in-time
Total Liabilities	`Liabilities`	$45.68M	USD	Point-in-time
Commitments and contingencies (Note 8 and 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 8 and 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 shares authorized, 146,581,624 and 126,411,808 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$6.00K	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 shares authorized, 146,581,624 and 126,411,808 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$5.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$220.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$155.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$869.35M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.47B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-761.80M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$300.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-570.61M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$758.31M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$355.06M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$711.84M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$466.19M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$397.42M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$298.97M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$782.29M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$344.65M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Research and development expenses	`ResearchAndDevelopmentExpense`	$111.78M	USD	3 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpense`	$43.05M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpense`	$149.28M	USD	3 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpense`	$41.58M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$10.03M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$44.13M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$15.92M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$29.98M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$141.76M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$193.40M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$51.61M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$58.97M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-193.40M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-58.97M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-51.61M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-141.76M	USD	3 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$395.00K	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$7.77M	USD	3 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$2.22M	USD	3 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$2.12M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-49.49M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-58.57M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-191.18M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-133.99M	USD	3 Qtrs
Net Loss Per Share of Common Stock, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-1.08	USD	3 Qtrs
Net Loss Per Share of Common Stock, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.40	USD	1 Quarter
Net Loss Per Share of Common Stock, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-1.41	USD	3 Qtrs
Net Loss Per Share of Common Stock, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.40	USD	1 Quarter
Weighted Average Shares of Common Stock Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	146,492.00	shares	1 Quarter
Weighted Average Shares of Common Stock Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	123,674.00	shares	3 Qtrs
Weighted Average Shares of Common Stock Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	124,035.00	shares	1 Quarter
Weighted Average Shares of Common Stock Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	135,457.00	shares	3 Qtrs

Cash Flow Statement 55 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-49.49M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-58.57M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-191.18M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-133.99M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$30.66M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$18.87M	USD	3 Qtrs
Noncash lease expense	`NonCashLeaseExpense`	$5.00M	USD	3 Qtrs
Noncash lease expense	`NonCashLeaseExpense`	$4.96M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$819.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$875.00K	USD	3 Qtrs
Gain on settlement of dispute	`GainLossRelatedToLitigationSettlement`	$336.00K	USD	3 Qtrs
Accretion (Amortization) of discounts and premiums on investments	`AmortizationOfDebtDiscountPremium`	$359.00K	USD	3 Qtrs
Accretion (Amortization) of discounts and premiums on investments	`AmortizationOfDebtDiscountPremium`	$-3.04M	USD	3 Qtrs
Prepaid expenses, other assets, and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-785.00K	USD	3 Qtrs
Prepaid expenses, other assets, and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-66.00K	USD	3 Qtrs
Operating lease liabilities (Right-of-use assets)	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-4.31M	USD	3 Qtrs
Operating lease liabilities (Right-of-use assets)	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-5.58M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$9.17M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$6.62M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$4.49M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$8.26M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-142.44M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-105.07M	USD	3 Qtrs
Maturities of short-term investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$358.49M	USD	3 Qtrs
Maturities of short-term investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$420.58M	USD	3 Qtrs
Purchase of short-term investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$353.88M	USD	3 Qtrs
Purchase of short-term investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$711.64M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$23.46M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.49M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$63.21M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-376.61M	USD	3 Qtrs
Tax payments related to shares withheld for vested restricted stock awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$283.00K	USD	3 Qtrs
Tax payments related to shares withheld for vested restricted stock awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$193.00K	USD	3 Qtrs
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$4.24M	USD	3 Qtrs
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$6.70M	USD	3 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$162.00M	USD	Point-in-time
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$567.04M	USD	3 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$567.00M	USD	Point-in-time
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$573.46M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.04M	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-37.81M	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$54.42M	USD	3 Qtrs
Cash, Cash Equivalents, and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$73.83M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.42M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$82.15M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.34M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$73.83M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.42M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$82.15M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.34M	USD	Point-in-time
Unrealized (loss) / gain on short-term investments	`UnrealizedGainLossOnShortTermInvestments`	$-65.00K	USD	3 Qtrs
Unrealized (loss) / gain on short-term investments	`UnrealizedGainLossOnShortTermInvestments`	$281.00K	USD	3 Qtrs
Acquisitions of property and equipment included in accounts payable and accrued expense	`LeaseholdImprovementsPaidByLandlord`	$8.06M	USD	3 Qtrs
Acquisitions of property and equipment included in accounts payable and accrued expense	`LeaseholdImprovementsPaidByLandlord`	$557.00K	USD	3 Qtrs
Conversion of convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	$2.00K	USD	3 Qtrs

Stockholders Equity 35 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$758.31M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$355.06M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$711.84M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$466.19M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$397.42M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$298.97M	USD	Point-in-time
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$18.87M	USD	3 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$30.66M	USD	3 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.71M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.60M	USD	1 Quarter
Tax payments related to shares withheld for vested restricted stock units	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-283.00K	USD	3 Qtrs
Tax payments related to shares withheld for vested restricted stock units	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-193.00K	USD	3 Qtrs
Tax payments related to shares withheld for vested restricted stock units	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-99.00K	USD	1 Quarter
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.24M	USD	3 Qtrs
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.70M	USD	3 Qtrs
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.52M	USD	1 Quarter
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$762.00K	USD	1 Quarter
Unrealized (loss) / gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$281.00K	USD	3 Qtrs
Unrealized (loss) / gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-133.00K	USD	1 Quarter
Unrealized (loss) / gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-65.00K	USD	3 Qtrs
Unrealized (loss) / gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-162.00K	USD	1 Quarter
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$567.04M	USD	3 Qtrs
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$43.00K	USD	1 Quarter
Common stock sold in public offering, net of offering costs (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	50,000.00	shares	Point-in-time
Cancellation of common shares from settlement of dispute	`StockCancelledDuringPeriodSharesOfCommonStock`	$-336.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-49.49M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-58.57M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-191.18M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-133.99M	USD	3 Qtrs
Ending Balance	`StockholdersEquity`	$758.31M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$355.06M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$711.84M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$466.19M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$397.42M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$298.97M	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-49.49M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-58.57M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-191.18M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-133.99M	USD	3 Qtrs
Unrealized (loss) / gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$281.00K	USD	3 Qtrs
Unrealized (loss) / gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-133.00K	USD	1 Quarter
Unrealized (loss) / gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-65.00K	USD	3 Qtrs
Unrealized (loss) / gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-162.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-191.25M	USD	3 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-49.62M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-58.73M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-133.71M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.